SCHEMBL30030778

SCHEMBL30030778

CC(C)(C)[C@@H]1Cc2c(nc3c(OC(F)F)cc(F)cn23)-c2[nH]c(=O)c(C(=O)O)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30030844 1.00 — —
SCHEMBL30032164 1.00 — —
SCHEMBL30031286 0.92 — —
SCHEMBL30030847 0.92 — —
SCHEMBL30031614 0.92 — —
SCHEMBL30031721 0.90 KDM4E (0.32) —
SCHEMBL30031695 0.90 KDM4E (0.32) —
SCHEMBL30031950 0.90 KDM4E (0.32) —
SCHEMBL30031474 0.87 IDH1 (0.31) —
SCHEMBL30031308 0.87 IDH1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022214937-A1 SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-13 — — WO claimed
WO-2022214937-A1 SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-13 — — WO disclosed
Send feedback